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Executive Summary _____________ 
__________________________________________ . c4 xa+9aan ,+ ann a.Kaan 
More than 150 individuals from developing countries, multilateral and bilateral development- 
assistance agencies, and international organizations and foundations met in Ottawa, Canada, from 
18-20 October 1993, to promote and increase the effectiveness of partnerships for improving 
health in the developing world. This Conference on a Future Partnership for the Acceleration 
of Health Development was co-sponsored by Canada's International Development Research 
Centre (IDRC), the World Bank, and the World Health Organization (WHO). Building on the 
World Bank's 1993 World Development Report (WDR '93) investing in Health, which has 
generated considerable interest among policy makers, development agencies, and the research 
community, the Conference sought to examine weaknesses in national and international programs 
for equity-oriented health development in developing countries, and to agree upon practical steps 
to increase the scope and effectiveness of partnerships and investments for health. 
Taking the World Development Report 1993 as their point of departure, Conference participants 
analyzed three interrelated problems. In renewed partnerships for equity-oriented health 
development: 
• How can we build capacity in developing countries to undertake health policy 
reform in support of sustainable health development? 
• How can we strengthen the relevance, coordination and contribution of health 
research for health reform in developing countries? 
• How can we increase, redirect and enhance investments in health development? 
Cutting across all three themes was a common concern for ensuring that both national and 
international resources for health be used in a manner that would move the health sector toward 
the following: 
• Greater access and equity for health care. 
• Greater congruence with the needs of populations. 
• Greater effectiveness and efficiency in allocation of resources. 
• Greater participation and accountability to the people being served. 
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• Greater sustainability for the long term. 
Such guiding principles of equity-oriented health reform would maximize health gains for the 
5 billion people living in developing countries and, especially, for the more than one billion 
poor. 
The Conference began with opening remarks from the Conference chairperson, Professor 
Vulimiri Ramalingaswami, Professor Emeritus of the All India Institute of Medical Sciences; Dr 
Keith Bezanson, President of IDRC; Dr Jean-Paul Jardel, Assistant Director-General of WHO: 
and Mr Armeane Choksi, Vice-President for Human Resources Development of the World Bank. 
Mr Choksi defined the main objectives and themes of the Conference in his address to the 
participants. This was followed by presentations and initial discussion of papers specially 
commissioned by \VHO, IDRC, and the World Bank, respectively, on the three central themes. 
The participants then met in three separate working groups. The main findings and 
recommendations for action were presented for discussion to a plenary session at the end of the 
second day. These recommendations were synthesized into a draft report, which was discussed. 
revised and generally supported by the participants on the final day of the Conference. 
Broad Conclusions 
The Conference was intended to generate a sense of the general principles for the way forward 
from WDR '93 and achieved remarkable consensus on both principles and general directions: 
• First, there was consensus that WDR '93 has opened a window of 
opportunity to take renewed action and apply increased energy to 
strengthen and support health policy reform and equity-oriented health 
development. There is unprecedented need to take advantage of this 
opportunity arising from the strong and growing interest in health policy 
reform in both the North and the South, and from an increasing 
commitment to partnerships for health as a key part of human resource 
development. Nevertheless, it was also a point of consensus that there is 
no need for new, large, or costly international institutional structures to 
address health policy reform. 
• Second, it was further recognized that immediate action is needed to 
determine and articulate the way forward, and that energy-intensive 
leadership on this front must be generated quickly before the opportunity 
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passes. There was consensus that this could be best initiated through the 
immediate establishment of one, or possibly two, participatory working 
groups or task forces under the auspices of WHO and the World Bank. 
Third, there was consensus that there is no magic formula, no simple 
path, no single route forward and no declaration of an easy solution. 
What emerged was reinvigorated determination and recommitted partner- 
ship to tackle the complex and difficult problems of health sector reform 
for equity-oriented health development without an exaggerated reliance or 
focus on a handful of selective technologies, disease approaches, or 
slogans. It was recognized that reform would involve difficult choices, 
to be made in partnership, in redirecting investments at both national and 
international levels. 
Action Items 
The foregoing points of agreement and the following action items suggest and recognize that an 
integrated approach to the three health development sub-themes of the Conference, capacity 
building, research and resources, is possible and desirable: 
On how can we build capacity in developing countries to undertake health policy reform 
in support of sustainable health development: 
There was support fo:r the establishment of a Network for Health Reform 
Capacity Building. It was agreed that a temporary Working Group needs 
to be established immediately to conceptualize and draft a detailed 
proposal for such a Network. WHO, in consultation with the World 
Bank, will take the irLitiative in convening this Working Group. Several 
guiding principles were offered for consideration in this process and are 
contained in this report. 
2. On how can we strengthen the relevance, quality and contribution of health research for 
health reform: 
It was agreed that an open and participatory review of current 
international health priorities for research should be conducted in light of 
the analytic framework presented in WDR '93, and additional innovative 
approaches or refinements that need to be developed. Ideally, this review 
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should be completed for the World Summit for Social Development in March 
1995. Following the recommendation made at the Bellagio Conference on 
Strengthening Research and Control of Infectious Diseases, held in September 
1993, WHO should serve as the Secretariat for this ad hoc review of health 
research priorities. Several guiding principles regarding the scope of research 
required in association with these priorities are contained in the report. A 
group of donors has agreed to fund this initiative. It is recognized that this 
review of health priorities from the international perspective will be 
complementary to that derived at national level (for example, via the Council 
on Health Research for Development (COHRED) and the Essential National 
Health Research (ENHR) strategy). It was further suggested that 
consideration be given to mechanism(s) to monitor domestic and international 
flow of funds to global and national health research and research networking. 
It was agreed that joint support was needed for testing the development and 
implementation of the nationally-defined health intervention package(s), health 
policy reform and improved donor coordination, in 6—10 interested 
countries. In this respect, the Canadian International Development Agency 
(CIDA), IDRC, the World Bank's Population, Health and Nutrition 
Department, several WHO programs and other interested agencies will work 
together in one such initiative. The initiative could entail estimates and 
analyses of national burdens of disease, development of adapted public health 
and clinical intervention packages, working with countries in the pilot 
implementation of the packages and research efforts to evaluate the 
approaches. This would allow the drawing of generic lessons for possible 
application in other countries. 
3. On how we can increase, redirect and enhance investments in health development: 
A Working Group is needed to examine issues related to increasing and 
redirecting investment in equity-oriented health development, some of which 
are outlined in this report. The World Bank, in consultation with WHO and 
major donors, will take the initiative for leading follow-up work in this area. 
Recognizing that such capacity building, health research, and increasing and redirecting investment 
in health are linked and necessary for health policy reform, WHO and the World Bank will 
determine whether the foregoing efforts will require either separate working groups or secretariats 
coordinating closely with each other, or one umbrella group. 
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Capacity Building for Health Policy Reform . .V. 
To support and accelerate health policy reform, resources need to be redirected both 
domestically and externally to improve the evident mismatch between the need for health policy 
reform and the low levels of capacity for undertaking this effort in countries at different levels 
of development. International agencies are already facing a high and growing demand for 
technical assistance in this area. 
The discussion was divided into two sections: the first on identifying the kinds of capacity 
building that are needed, and the second, on identifying how to implement these suggestions. 
What Kind of Capacity? 
The concept of capacity building has three components: human resources development, 
institutional development and (the creation of) an "enabling environment." Four steps in the 
reform process were discussed in relation to the components: 
• Developing a health sector/policy framework; 
• Priority setting; 
• Organizational assessment and identifying options for change; and 
• Implementing change. 
Different actors in the change process have distinctive training needs in management skills, in 
health economics, in understanding the role of other sectors on health, and in adapting tools for 
priority setting. 
Capacity building methods discussed ranged from the use of intercountry comparative 
experiences, short seminars for senior-level policy makers and basic training in relevant technical 
disciplines. Essential National Health Research (ENHR) was felt to have an important role. 
ENHR is particularly important in the priority-setting process and also in the contribution to the 
other components of the reform process. Clearly, policy-relevant research plays an essential and 
reinforcing role in integrating improved financial investments for health, capacity building for 
health development and sector reform, as well as obviously improved quality research. 
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In organizational assessment and in the implementation of change, the contributions of 
behavioral, political, and management sciences were recognized. The importance of developing 
problem-solving training approaches was also emphasized. 
How Can Partnerships Be Developed? 
International partnerships between institutions from developing countries and industrialized 
countries, as well as multilateral organizations potentially could strengthen national efforts and 
help increase the resources devoted to the process of reform. Organizational mechanisms need 
to be set up that facilitate consensus building and balancing of interests and expertise. There 
was support for the idea that a network be established. A Working Group will be convened to 
take on the task of drafting a detailed proposal for a Network for Health Reform Capacity 
Building. WHO, in consultation with the World Bank, will take the initiative for convening this 
working group. 
Several guiding principles were suggested which would direct the functions and tasks of the 
network. These are: 
• to focus on equity-oriented strategies (including gender disparities); 
• to ensure partnership in governing the network; and 
• to increase country capability for undertaking health policy reform, 
for example, by strengthening evidence-based decision-making 
capabilities. 
The functions of the network will be: 
• To act as a clearinghouse to improve sharing of: 
(a) Information; 
(b) Technical assistance; and 
(c) Experiences on health policy reform. 
• To support and assist countries in the formulation and 
implementation of health policy reform; and 
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To help develop, refine and promote the use of tools and strategies 
for health policy analysis and reform. 
The institutions participating in each node of the network, and the network as a whole, should 
have clearly defined functions. The network requires a central pivot or hub. Most importantly, 
the network should provide a clearinghouse function (access mechanism) through which 
developing countries implementing health policy reform can share other countries' similar 
experiences and concerns and gain access to institutions in the network for information, technical 
advice and long-term funding. 
To support and steer such a network, an international initiative for health policy reform could 
be developed with the support of a core group of sponsoring agencies and developing countries 
committed to providing financial and personnel resources. 
The core group could also guide the initiative on behalf of a larger group of participants, 
including collaborating institutions, developing country representatives, representatives of 
bilateral development agencies and other United Nations organizations. This larger group might 
be convened as a global advisory panel. An independent expert group could advise and guide 
the initiative. This would be a group of persons acting in their individual capacities as experts 
not only in the public health arena, but also in the area of health policy reform. 
The initiative would require a network secretariat that would facilitate: 
• Research and development to improve analytical and 
implementation tools for policy reform; 
• Channelling support to strengthening national and institutional 
capacities for reform (particularly, but not exclusively, in 
developing countries); 
• Analysis of country experiences to further our understanding of 
health policy reform, and 
• Promotion of and participation in reform within countries. 
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The size and functions of the network secretariat would need to be agreed to by the core donors 
but, at a minimum, a clearinghouse function would be required, and the research and 
development work on such methodological/analytical tools as the global burden of disease and 
the cost-effectiveness of interventions presented in the World Development Report 1993 should 
be continued in partnership with other collaborating institutions. WHO has agreed to undertake 
the task of defining a proposal on the composition, functioning and resource requirements of the 
network. It will be presented for consultation to the interested parties. 
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Relevance and Contribution of Health Research 
_________________________________________ .... .. * 
Research is an essential input to further health policy reform and health development. 
The following describes guiding principles, identifies key issues, and collects main conclusions 
of the discussions as part of an effort to maximize the opportunity provided by the release of 
WDR '93 to strengthen health research initiatives already underway and to accelerate national 
health development. 
Scope 
• Improvements in health are not brought solely by changes in the 
health sector. Thus, other sectors, such as education, agriculture 
and water, must be included in the agenda for research in order to 
drive and advance health-related development. 
• Research is needed at the community, country and global levels. 
• Better rapid assessment-type research methodologies are needed to 
support decision-making. Biomedical, as well as applied, public 
health, health promotion, and qualitative, participatory and 
community-based research are all important forms of health 
research. Greater emphasis needs to be placed on social and 
behavioural science approaches to health research. 
Priority-Setting 
The Commission on Health Research for Development and the WDR '93 draw attention to the 
mismatch between the global burden of illness, which occurs predominantly in developing 
countries, and health research funding priorities, which are predominantly directed to problems 
of industrialized countries. Within developing countries, relatively small amounts of health 
research are dedicated to the problems of greatest concern to the populations and policy makers. 
Thus, there is a need to develop methods and approaches for priority setting that take into 
account issues such as local burden of disease, opportunities for cost-effective impact, 
comparative advantage and leverag:ing of resources. 
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Community, National, and Global Levels 
• Health priorities set by communities may differ from those that 
emerge from burden of disease and cost-effectiveness analysis. 
There is a strong need for more micro-level, socio-cultural- 
economic research to identify local priorities. 
• Countries need to be supported in setting national health research 
priorities (for example, Essential National Health Research 
strategy). The international community should respond to country 
priorities by making funds available to assist in building capacity 
to set such priorities and to implement research. If countries have 
their own national health research plans, donor priority setting will 
be facilitated. 
• There is an urgent need to review current international health 
priorities for research; and this should be conducted in the light of 
the analytic approach illustrated in WDR '93 and additional 
approaches that need to be developed. Ideally, this review should 
be completed in time for the World Summit for Social 
Development in March 1995. Following the recommendation 
made at the Bellagio Conference on Strengthening Research and 
Control of Infectious Diseases in September 1993, WHO should 
serve as the Secretariat for this ad hoc review of health research 
priorities. A group of donors has agreed to fund this initiative. 
This review of health priorities from the international perspective 
will be complementary to that derived at national level (for 
example, via COHRED and the Essential National Health Research 
strategy). 
• The review should be an open and participatory process that will 
allow full involvement of agencies and organizations engaged in 
national and international health policy and research (especially 
WHO, the World Bank, the United Nations Development 
Programme (UNDP), United Nations Children's Fund (UNICEF), 
the European Community, COHRED, etc.). 
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Integrat/on/Coordin at/on 
Certain problems need to be approached comprehensively by 
involving various types of research (biomedical, clinical, health 
systems, field, socioeconomic, etc.) to better understand the 
complex determinants of health and health intervention 
possibilities. 
• Now more than ever there is an excellent environment for 
coordination, linkage, and collaboration between researchers and 
research networks at national and international levels. 
• Existing networks, such as WHO Special Programmes (HRP, 
TDR, and GPA), COHRED, Social Sciences in Medicine, 
University Partnersh:ips Project of the Network of Corn munity- 
Oriented Educational Institutions for Health Sciences, and the 
International Clinical Epidemiology Network (IINCLEN) could 
provide better support to national and international research. 
These links will also provide support to Essential National Health 
Research strategies in country-level priority setting. 
• There is a need to support studies on priority-setting processes for 
the global agenda. This should involve other agencies and have 
strong links to COHRED. In the process, coordinating 
mechanisms, such as COHRED, must be strengthened. Countries 
could organize donor round tables to extend support to national 
agendas of research and research capacity strengthening. These 
round tables should be linked to broader donor coordination 
processes at the country level. 
• At a minimum, coordination could involve the exchange of 
information. This would allow identification of unnecessary 
duplication or gaps and could eventually lead to collaboration and 
improved coordination. Coordination can also play a major role 
in integrating research across sectors. 
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Increasing and Redirecting In vestment 
We need to help: 
• to promote healthy public policy formulation' within countries 
which is more research or evidence based. 
• to better balance the allocation of research funding between current 
problems of North and South, while recognizing the need to 
address problems emerging from the current health transition. 
• to mobilize domestic resources for country research priorities. In 
addition, we need to recognize fully the "in kind" contribution of 
recipient countries used in support of their own priority research. 
• to monitor domestic and international flows of funds to global and 
national health research and research networking. 
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Increasing and Redirecting In vestment 
Principles, Issues, and Conclusions 
• Improving domestic policies, resource mobilization and resource 
allocation are central to health development. Nevertheless, 
external assistance can play an important catalytic role in health 
policy reform. 
• External assistance has, in many instances, not been conducive to 
the development of equitable and gender-sensitive health policies 
and has not sufficiently focused on support for institutional 
capacity building for health policy reform and sustainable health 
development. Narrow technical, epidemiological and economic 
approaches need to be replaced by a broader approach that 
recognizes the complexities of health institutions and systems. 
• Improvements in resource allocation, both from domestic and 
external sources, are needed. Packages of highly cost-effective 
public health interventions and clinical services should be 
developed at the country level and should be funded by public- 
sector financing and external assistance before new public 
investments are made that support less cost-effective services. 
Private funds and cost-recovery schemes can be used to finance 
other clinical services. In general, development partners should 
strive to promote greater equity and efficiency in public 
investments, accelerating the provision of basic services for all 
while restraining the growth of publicly funded, specialized 
services that primarily benefit the well-to-do. 
• The donor community needs to reconsider how external assistance 
can more effectively support the reform processes. This calls for 
longer-term commitments and more flexible, cooperative 
mechanisms based on agreed-upon objectives and priorities. The 
donor approach should be more program oriented, reflecting 
country priorities. 
13 
CONFERENCE ON A FUTURE PARTNERSHIP FOR 
THE ACCELERATION OF HEALTH DEVELOPMENT 
18-20 October 1993. (tawa, Cwtada 
• Donors and ministries of health need to improve their ability to 
negotiate for additional funding for health, based on the strong 
arguments for the role of health in improving welfare, economic 
growth and reducing poverty. The economic arguments presented 
in the World Development Report provide good rationales for 
investing in health. A broader audience could be reached by 
developing alternative communication channels (simple visual 
presentations, or more sophisticated videos or computer software) 
with the report's messages. The point is to reach out broadly, 
beyond the health community, to decision makers at donor and 
developing country level. 
• Donors need to focus more effort on strengthening and building 
developing country capacity to negotiate, manage, coordinate and 
account for internal and external resources. 
• In addition to resource reallocation, incremental financing should 
be encouraged from: (a) new donors, (b) the private sector and (c) 
continued growth in financing from multilateral aid agencies. It 
is recognized that in the current environment of increasing 
competition for limited resources, traditional donors may not be 
able to increase significantly their external assistance; however, if 
a good case can be made for investments in health, reallocation 
from other sectors is possible. 
• The pros and cons of setting up a new global fund (like the Global 
Environmental Fund) to support certain types of high-priority 
health activities were discussed. Before thinking about this new 
mechanism, articulation of a strategy for this is needed that 
includes assurance that these resources will be additional. 
Existing funding efforts must not be weakened. 
• Donor coordination has much scope for improvement; this needs 
to be at the country-level and led by governments. It does not 
require expensive, new international mechanisms. 
• The potential for establishing or improving existing information 
systems to monitor aid flows, projects in the pipeline, country 
policy work and the impact of investments needs to be examined. 
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• Well articulated country-specific health policy/priorityframework.s 
would help guide domestic policy as well as enable donors to 
justify increased funding. Donors could assist countries in the 
development of these frameworks. The World Development Report 
1993 and other documents such as The World Bank's Better Health 
in Africa can be useful in assisting in the development of such 
frameworks. 
• Efforts should be directed in donor countries to boost public 
awareness and support for external assistance for investment in 
health. 
• It was agreed that joint support was needed for testing the 
development and implementation of nationally defined health 
intervention package(s), health policy reform and improved donor 
coordination, in 6—lO interested countries. In this respect, CIDA, 
IDRC, the World Bank's Population, Health and Nutrition 
Department, several WHO programs and other interested agencies 
will work together in one such initiative. 
• The challenges of new and existing health problems, public-sector 
reform and health-reform efforts are placing demands on donors' 
skills and experiences. Donors can reach out more to collaborate 
with other institutions, particularly at the local level, to improve 
the quality of their efforts toward sustainable development. 
• Although the setting of global financial targets for external 
assistance may be inappropriate, the setting of targets for external 
resources at the country level for specific programs and types of 
assistance may be quite useful. 
• It was recommended that a working group be set up (either as part 
of a larger working group emerging from the Conference or as a 
separate working group coordinating closely with others) to 
examine these and other issues related to increasing and redirecting 
investment in equity oriented health development. 
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Commissioned Discussion Paper 
Capacity Building for Health Systems Reform 
The World Development Report 1993 is a major plafor,n for identfjing and 
prioritizing goals in the health sector. But these goals can only be reached 
through deep reform and improvement of existing health systems, and such reform 
can only be implemented at country level. Capacity building in national health 
systems is the refore fundamental to the implementation of the WDR agenda. This 
paper addresses four questions: 
1. What are the objectives of capacity building for health system reform? 
2. What are the components of the reform process, what are the greatest challenges, 
and what knowledge is available to assist reform? 
3. Given the requisite knowledge, what people need which skills, where may these 
skills be found, and what new training approaches are needed? 
4. What are the options for a closer partnership to support capacity building for 
health system reform? 
1. What are the objectives of capacity building for health system reform? 
The World Development Report 1993 has demonstrated beyond doubt that an investment in 
health is an investment in development. Yet the health of the people of many countries is 
weakened as much by institutional incapacity to deliver appropriate disease prevention, control 
and treatment as by disease and disability themselves. Governments and donors will continue 
to be unwilling to invest more in health if health systems continue to perform with great 
inefficiency. 
For example, at a recent meeting on "Global Infectious Diseases: Strengthening Research and 
Control" (convened by the Rockefeller Foundation in Bellagio, Italy, on 30 August - 3 
September 1993) identified "a much better job can be done if assessing the extent and intensity 
of the morality and disability due to these diseases; of setting priorities for applying available 
knowledge and technology through public health and primary health care programs; and of 
marshalling the political and economic support required to translate those priorities into effective 
action". 
These goals apply not just to infectious diseases, but to all aspects of health, particularly in 
developing countries; and they apply not only to global and regional assessments, but above all 
to national policy and health systems. 
Action to improve health must finally be taken at country level; and it is there where capacity 
must be built. Any coordinated system of capacity building for health policy reform must 
therefore aim at least to: 
• Increase knowledge and country capacity in the four components of the reform 
process: establishment of a health policy framework, priority setting, assessment 
of existing health system organizations, and the implementation of reform. 
• Increase the transfer of practical experience among countries. 
• Increase the availability of international expertise for assistance at national level. 
• Increase short-term and long-term training in relevant disciplines such as 
economics, epidemiology, the behavioural, social and political sciences and law. 
• Develop more cost-effective training methodologies - such as distance learning. 
• Increase the availability of resources available to health. 
• Strengthen international collaboration on health policy reform, health systems 
development and institutional arrangements. 
• Further refine techniques to assess disease burdens, and adapt and apply them 
at country level. 
• Further develop cost-effectiveness studies, particularly on clustered interventions 
(to share delivery costs), and adapt and apply them at country level. 
• Develop effective methods of health system decentralization and their relation to 
local political institutions. 
• Improve methods of efficient distribution of health technologies, at international 
and country level. 
• Develop methods of information gathering and monitoring which meet the needs 
of the periphery and the centre. 
2. What are the components of the reform process, what are the greatest 
challenges, and what knowledge is available to assist reform? 
The establishment of a reform process requires four steps to be taken in every country, each of 
which has its own requirements of skills and knowledge: 
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• The establishment, of, and commitment to, a health policy framework. 
• The setting of priorities within that framework. 
• The assessment of existing organizations. 
• Most difficult of all: the practical implementation of change. 
The World Development Report 1993 has made a major contribution to the second of these - 
priority setting - but if reform is to become a reality, knowledge and country capacity must be 
increased in all four areas. Moreover, reform must be seen as a continuous process; countries 
are constantly changing in their political, social, environmental and economic circumstances, and 
capacity building for reform must be seen as a continuous rather than a singular event, and will 
require the establishment of an intelligent and flexible responsiveness in countries as well as at 
the global level. 
Here we address the four components of the reform process in turn, and consider what new 
knowledge is required to guide effective reform. 
2. 1 Establishment of a health policy framework 
A health policy framework establishes commitments. It gives operational definition to a 
country's (or region's) notions of equity and efficiency, and sketches the responsibilities of 
different government and non-government actors, and of the public. Such frameworks are a 
valuable means for eliciting support from important interest groups, and for establishing vision 
and leadership. 
To create a health policy framework is primarily a consensus-building activity on the principal 
axes for change, and serves to set out the targets, organizational changes and new policy 
instruments in broad terms. Important political skills and processes are involved in the 
agreement of the policy framework, and in the subsequent building of support and consensus 
around it. 
Available knowledge and technical guidance in this area is slight. 
2.2 Setting priorities within the frame work 
The second component of reform is the setting of priorities consistent with the health policy 
framework. Priority setting must be based on a recognition of overall resource shortage in 
relation to need, and an acknowledgement that transparent, consistent procedures for setting 
priorities are important for greater political accountability. 
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Available knowledge and technical guidance in this area is strong, but largely limited to global 
priority setting. The World Development Report 1993 provides important technical support with 
its approach to the measurement of disease burden and the cost-effectiveness of interventions. 
Substantial supporting literature on priority setting also exists, and much has been used in the 
past in assessing resource allocation priorities for health at country, regional and district level. 
This is thus an area in which a relatively good basis of technical knowledge for capacity building 
exists. 
However, the indicative global priorities set out in World Development Report 1993 should be 
used for national or sub-national priority setting only with appropriate adaption, both to local 
data, and to local perceptions of what constitute priority problems. Unless local expertise and 
experience is included in the process of priority-setting, an approach by pure principles to the 
problem will inevitably exclude country-level decision-makers from a sense of ownership and 
therefore of conviction about the priorities. 
2.3 The assessment of organizations 
The third component of reform is the assessment of the strengths and weaknesses of existing 
health system organizations. 
Available knowledge and technical guidance in the analysis of health system organizations is 
considerable, but not always appropriate. A wide variety of tools and techniques exist, though 
the majority are driven more by the concerns of external assistance agencies than the concerns 
of health system managers, and few have found their way into routine use as assessment tools. 
Much remains to be achieved in identifying organizational and financing mechanisms which will 
create incentives for the adoption of more sustainable cost-effective practices. However, a 
considerable body of knowledge and experience has been generated about the barriers to the 
adoption of such practices. 
2.4 Implementation of reform: the key task 
The fourth and most difficult component of the reform process lies less in analysis than in 
implementation: in this process, policies and priorities can be modified or destroyed. 
Implementation is a special problem in the least developed countries. In addition to the 
handicaps of worse health, less resources, and fragile organizational structures, decision makers 
in poor countries have jobs which are in some ways more compler than those of their 
counterparts in industrialized countries. For example, they have to contain or control external 
donors who, with their command over money, become alternative sources of policy and 
implementation in the health sector. In addition, the negotiation of new responsibilities, design 
of new structures and procedures has to be undertaken - and resolved - with a range of 
individuals, professional groups and organizations inside and outside the Ministry of Health, 
necessitating a range of skills outside the medical or public health curriculum. 
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An environment of "loose organizational loyalty" in much of the public sector of developing 
countries has also been described by a senior health planner1 as contributing to a lack of concern 
with the public objectives of the organization, or to the needs of the consumer. This will 
interfere with the adoption of rational techniques of decision-making at all levels. 
Health sector managers in poor countries thus have a bigger job, a growing set of tasks, and a 
working climate whose ethos may be much less "results-oriented" than that of public 
bureaucracies in richer countries. Implementing reform therefore entails government having the 
capacity to make and manage its own policy, to negotiate and coordinate the separate priorities 
and accounting requirements of external assistance, and to cope with an often unsupportive 
bureaucracy. 
Available knowledge and technical support on implementation issues is conspicuously weak. 
The World Development Report 1993 brings powerful analytical tools to bear on the problems 
of resource allocation in the health sector, but has little to say about the short-term steps to 
better management, or to managing the transition to a more cost-effective set of services. 
Building capacity for implementing change is, in general, an area poorly supported by guidance. 
despite sometimes over-enthusiastic claims. We do not yet know, for example, whether or how 
a large scale cost-recovery system can be designed that will cover its own costs, retain the funds 
to improve services at local level and result in better access to care for the poor. Nor do we 
know with any accuracy what the economic and administrative capacity of a country or region 
needs to be for a social insurance mechanism to be a viable and sustainable means of financing 
health services for the whole population. Above all, we should be clear that the "answers" to 
strategies to improve implementation are not likely to be the property of a single group of actors. 
whether academic centres or international agencies. The experience of health sector managers 
who have implemented change in their own country (for example New Zealand, Ghana, Sweden. 
Chile, UK, Canada, Hungary), may be of direct interest and value to other countries. New 
sources of transferable experience, including from political, legal and managerial perspectives, 
are urgently required. 
2.5 The need for new knowledge 
As the above paragraphs demonstrate, the tools and experience needed for health policy reform 
are unevenly developed and distributed. In existence, or under development, are tools and 
methods for better understanding the impact of macroeconomic trends and policies on health, 
for projecting revenue and cost trends, for understanding treatment-seeking behaviour, for 
making a comprehensive analysis of health related activities at the local level, for priority 
setting, estimating the burden of disease and the determinants of ill health, and for measuring 
the cost-effectiveness of individual interventions and of intervention packages. Generic and 
'Asamoa-Baah, A: Jdenr?fl cation of Needs in Health Economics in Developing Countries, paper produced for 
WHO Task Force on Health Economics, August 1993. 
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national research is needed to identify the legal, organizational and financing changes which will 
support and encourage the adoption of acceptable packages of priority interventions, in both the 
public and private sector. Comparative analytical work must also be undertaken to understand 
what works, what does not work, and why. 
3. Given the requisite knowledge, what people need which skills, where 
may these skills be found, and what new training approaches are needed? 
The use of disability-adjusted life years (DALYs) in World Development Report 1993, as one 
step in the process of priority setting, combines the approaches and data of economics and 
epidemiology. These two disciplines are necessary for a holistic approach to health sector 
reform, but as has been illustrated above, they are not sufficient. The perspectives of behavioral 
science and management sciences are also necessary, together with important inputs from 
political sciences and law. Transfers of experience, from practitioners (as opposed to teachers) 
of health system reform, are of great importance. However, few, if any, health sector 
specialists can be expected to combine and use all of these perspectives. 
3. 1 What sort of people need which skills 
At a global level, a rough schematization of skill needs may be helpful (see following table), but 
will always require adjustment to take account of individual countries' differences in size, 
educational levels, etc. Few people, if any, need a working familiarity with the whole range 
of reform-relevant skills. 
Decision Level Skills needed (type and level) 
Top decision makers (Minister) PS, 
Cabinet, health and related sectors 
Awareness of contributions from 
economics, epidemiology, social, legal and 
political sciences 
Directors of Planning, budget, health sector Working technical competence in one or 
more of above, ability to assess technical 
material from others 
National/regional health directors, 
categorical program chiefs, district 
management team 
Working competence in epidemiology, 
resource allocation principles, management 
information systems, personnel, logistics, 
etc. 
Specialist skills (inside or outside health 
sector) 
Health economics and financing, 
management accounting, contract setting, 
organizational behaviour, industrial 
relations, etc. 
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3.2 Where may these skills be found? 
Existing capacity building of the formal type - training and policy-related research - is provided 
by a wide variety of institutions in developed and developing countries in all these areas, but 
rarely, if ever, with the rationale of supporting health reform. Partly as a result of training in 
developed country institutions, and partly through developing their own training activities, a 
number of developing countries now have a nucleus of policy-analytic skills with a specific focus 
on health (for example Thailand, Philippines, Kenya, Mexico). These undertake both applied 
research and training. A much larger number of countries have reservoirs of analytical and 
managerial skills which, with relatively small investments to orient them towards health issues 
and the health sector, could become powerful domestic bases for the debate and analysis of 
health reform (for example India, China, Egypt, Brazil, Russia). 
External support for capacity building has come from relatively few sources. Only the 
International Health Policy Program (IHPP) is a "dedicated" capacity building agency in this 
area, and IHPP's focus has been on learning through policy-relevant research. For several 
years, different programs in WHO have been supporting a number of institutions in developing 
countries to develop a variety of research and training activities in health economics and 
management, in addition to sponsoring short, country-based training on issues such as cost 
analysis, cost recovery and strengthening district planning and management. The World Bank, 
through the Economic Development Institute, has cosponsored a number of short training-in- 
health economics seminars, some in collaboration with WHO and other opportunities in this area 
continue to be in Cambridge and Boston (USA), and London and York (UK). The disciplinary 
focus of training and applied research on health reform issues needs to be broadened from 
economics and epidemiology, to include the perspectives identified in the preceding paragraphs. 
Relevant skills and experience are clearly to be found in a much wider range of institutions than 
those university departments presently specializing in international health, or health economics: 
• Some countries, developed and developing, have specialist, not-for profit health 
management institutions dedicated to domestic capacity building and technical 
advice (for example the Danish Hospital Institute; the Centre for Educational 
Development in Health, Arusha; the King's Fund, Britain). 
• Many countries have public sector management training institutions which have, 
or could develop, training and research on health reform. 
• Most countries have potential sources of technical support in the for-profit sector 
(for example in management accounting, purchasing, equipment maintenance). 
• Countries which have been implementing health reform for several years have 
important lessons to deliver from their practical experiences. 
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Key individuals - advisors or managers - from these countries are important potential resources 
for other countries. At present, the transfer of such experiences appears to be on a small scale 
and ad hoc basis. Much better use could be made of existing skills and experience - in countries 
and among countries. A more planned and better coordinated approach by international agencies 
working in health could be an important catalyst for such an efficiency improvement. 
3.3 What new training approaches are needed? 
Current practice includes many different capacity building strategies, from postgraduate degree 
programs to on-the-job learning. Existing courses often cater to people from a wide variety of 
backgrounds with very different responsibilities. 
There appears to be big potential gain from rethinking capacity building from the perspective 
of individual countries, in addition to defining a curriculum around a topical (and genera) set of 
issues. Training through courses or applied research seems to be dominant at present, though 
this may be simply because such activities are easiest to identify. 
There has been little evaluation of the effectiveness of different training options and institutions, 
and little experimentation with, for example, distance learning methods, training of trainers or 
institutional development strategies. Closer consideration of the cost and effectiveness of 
country-based training, intercountry training, and international training activities is therefore 
necessary. A review of methods and their effectiveness, as well as target groups and areas of 
content, is also needed. 
4. Options for a closer partnership to support capacity building for health 
system reform 
The essential support for health system reform at both national and international levels is an 
international partnership to ensure that an appropriate amount of resources is devoted to the 
process, and to ensure that these resources are efficiently and effectively utilized. 
This partnership must balance the work and research needed on generic, global issues which can 
be analyzed and promoted from central level, and the need for essential country-level work - 
particularly on implementation problems - which are rooted in the economic, political and 
cultural realities of each country. 
To best serve the needs of national programs as well as those of the international development 
community, the organizational mechanisms which are established will need to provide for 
"ownership" by many participants, including major donors and developing countries themselves. 
The owners should be expected to contribute resources, but also to play a key and influential 
role in the policy reform process itself, so an appropriate balance of interests and experience 
must be established. 
Conference Discussion Paper B. 1 - viii - 
Three main procedural options are possible. The first, "least change" possibility is simply to 
use the impetus from the World Development Report 1993 to signal the need for greater priority 
(and resources) for those agencies currently working towards the development of analytical 
capacity for health policy making and implementation in the developing world. Periodic 
international meetings would be necessary to bring the main actors together, possibly to consider 
joint activities. Agencies would continue to tackle the above questions much as they always 
have done. 
The second option lies at the other extreme: the creation of a special-purpose entity with a global 
mandate based on the same objective. Such an entity could have various forms. It could be an 
International Committee, with resources and an agenda, rather like the Independent Commission 
on Health Research, whose tasks would be established and monitored by an advisory body 
representing groups such as those at Ottawa. Or it could also be a larger and more permanent 
construct, such as the Africa Capacity Development Foundation. 
The problem with the first option is that it lacks punch and continuity. The second option 
certainly involves duplication - few of the agencies participating in this meeting will consider 
themselves wholly inactive in the field of capacity building for health policy analysis, and at 
least one agency, the International Health Policy Program, is already dedicated to the above 
overall objective. 
The third option would be to adopt a network approach. The many interested parties would be 
involved in a network in which each node of the network, and the network as a whole, would 
have clearly defined functions. The network would need an identifiable central pivot or hub. 
And most importantly, the network should provide an access mechanism through which 
developing countries implementing review and reform can achieve access to other countries with 
similar experiences and concerns, and to institutions in the network for information, technical 
advice, and long-term funding. 
To support and steer such a network, an international initiative for health reform could be 
developed with the support of a core group of sponsoring agencies committed to provide 
financial and manpower resources. 
The core group of sponsoring agencies could also act to guide the initiative on behalf of a larger 
group of participants, including collaborating institutions, developing country representatives, 
representatives of bilateral development agencies and other United Nations organizations. This 
larger group might be convened as a global advisory panel, but could evolve later on as a "Joint 
Coordinating Board" (to use the term for the analogous structure in the UNDP/World 
Bank/WHO Special Program for Research and Training in Tropical Diseases - TDR). An 
independent expert group would also be envisaged to advise and guide the initiative. This would 
be a group of persons acting in their individual capacities as experts in this field. 
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The rationale for such an organization would not be to empower a large central bureaucracy, but 
to empower a network or consortium of collaborating countries and institutions which would be 
the main strength of the initiative and provide the major foci for research and development, data 
acquisition, debate on generic issues of policy reform and implementation of reform activities 
in countries, directed to overcome identified barriers to better health and health-care delivery. 
The initiative would require a network secretariat which would catalyst (through the network) 
and itself participate in several key areas: research and development on improving policy 
analytical and implementation tools; channelling support to strengthening national and 
institutional capacities for reform (particularly but not exclusively in developing countries); 
analyzing the information received in order to play a leadership role in setting the agenda for 
policy reform; and promoting and participation in the actual reform processes within individual 
countries. 
The size and functions of the network secretariat would need to be agreed by the owners, but, 
at a minimum, a clearinghouse function would be required, and the research and development 
work on the global burden of disease and the cost-effectiveness of interventions begun with the 
World Development Report 1993 should be continued in partnership with other collaborating 
institutions. 
WHO sees its own immediate role in this process as two-fold: firstly, intensifying its own 
country-specific support activities for health sector reform; and secondly, securing a more 
regular, systematic and long-term set of linkages with other partners around the globe, in both 
the developed and less developed countries. 
As a contribution to the discussions which will need to take place, WHO can offer its own vision 
of one option in which WHO - in close partnership with the sponsoring agencies - would house 
the secretariat for the initiative. But this certainly does not preclude other options being 
discussed. 
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Commissioned Discussion Paper 
Strengthening the Contribution of Health Research 
issues, Needs, Options, Questions 
L issues 
Health research can clearly make an important contribution to development and human well- 
being. The World Bank's 1993 World Development Report (WDR) on health presents 
persuasive evidence concerning the importance of better health for development; and it cites 
numerous examples to support its conclusion that "investments in health research and 
development have yielded high returns in better health." In doing so, the WDR confirms the 
findings of the earlier, 1990 report of the Commission on Health Research for Development (the 
Commission) 
2 
The instances where research has contributed to health advances are many. The WDR refers 
to one important set of examples in noting that "the programs for tropical disease research and 
human reproduction funded by donors and executed by WHO have produced a number of 
improved drugs and diagnostic tests .. . " The Commission report describes the central role of 
research in the successful global anti-smallpox campaign: the development of freeze-dried, heat- 
stable vaccine, the bifurcated needle enabling briefly-trained workers to immunize large numbers 
of people; and field research that shifted the program's focus from mass immunization to 
surveillance.4 Many other examples come readily to mind: for instance, the development of 
oral rehydration therapy at the International Centre for Diarrhoeal Disease Research, 
Bangladesh, and cooperating institutions. 
Yet despite these impressive contributions, no one, least of all the authors of the two studies just 
cited, would claim that the world's health research programs as they currently exist are realizing 
more than a fraction of their full potential. With improvement, the world's health research 
system could be making a much greater contribution than it has to date. Some of the most 
frequently-cited areas for improvement are: 
A. Quantity and Quality 
1 International Bank for Reconstruction and Development, World Development Report 1993: Investing in Health 
(New York: Oxford University Press, 1993), P. 168. 
2 Commission on Health Research for Development, Health Research: Essential Link to Equity in Development 
(New York: Oxford University Press, 1990). 
1993 World Development Report, p. 168. 
Health Research, p. 15. 
A. Quantity and Quality 
While data limitations prevent firm conclusions, the quantity of research on developing country 
health problems appears to have been stagnant or declining in recent years. As noted in the 
WDR (and one of the other Ottawa Conference background papers), the amount of development 
assistance for health -- a major source of support for health research -- has remained constant 
in capita terms and has been declining as a percentage of the total.5 Speaking more directly 
to the question of health research , the Commission observed that, "although solid data are 
not available, investment in research on developing country health problems has probably been 
static or declining over the past decade. 
Both the WDR and the Commission report make strong cases for reversing this trend by pointing 
to numerous areas in need of further attention. In the case of the Commission, the emphasis is 
on research at the national level, especially on what it terms Essential National Health Research - 
that is, research on country-specific problems that "addresses health needs, disease profiles, 
resource allocation, program evaluation, health financing, and other issues concerning the 
objectives and operation of a country's health system."7 The WDR both seconds this concern 
for national-level research and provides a discussion of research needs at the international level.8 
Quality is as important as quantity, of course; and it is difficult to avoid the impression that 
much of the research now being done is of inadequate scientific quality to provide valid findings. 
The Commission faces this issue frankly in noting the many constraints under which developing 
country researchers labour and in concluding that, "research quality, admittedly a difficult 
parameter to measure, tends to be marginal in many cases, limiting confidence in the usefulness 
of research results."9 
B. Relevance 
A related, perhaps even more cogent argument in favour of reforming as well as expanding 
health research lies in the importance of ensuring research's relevance for health improvement. 
The limited relevance of much current health research is particularly obvious with respect to the 
health needs of the poor. As the members of the Commission reported, "we have found a gross 
mismatch between the burden of illness, which is overwhelmingly in the Third World, and 
investment in health research, which is overwhelmingly focused on health problems of the 
1993 World Development Report, p. 165. 
6 Health Research, p.36. 
ftj, p.20. 
8 1993 World Development Report, pp. 153-55. 
Health Research, p. 47 
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industrialized countries."o In 1986, the Commissioners determined, only 5 percent of all 
health research was devoted specifically to health problems of developing countries, where some 
80% of the world's people live. For each year of potential life lost in the developing world, 
only 1/2 of 1 % as much was spent on health research as was expended for each year lost in the 
industrialized countries.1' 
Numerous more specific illustrations of the problem are also available from the WDR and other 
sources. For example, population-based considerations of need or potential impact on health 
conditions frequently plays only a limited role in the establishment of health research priorities. 
As a result, many striking gaps exist, with woefully inadequate amounts going to research on 
many issues of particular importance to very large numbers of the poor.'2 Product 
development, technology assessment, and health policy are being neglected.'3 Health 
information systems absorb large amounts of resources, but produce little information that can 
be used in program management.'4 
Much health research is believed to be irrelevant in yet another sense. That is, even when it 
corresponds to what epidemiologists consider important issues, it can fail to respond to the health 
problems of greatest concern to policy makers and the population at large. 
C. Coordination 
Poor coordination is everyone's bête noire; everyone has his or her favourite horror stories. The 
WDR both speaks articulately about the dangers of fragmentation and provides illustrations of 
these dangers and actions that have been taken to counter them.'5 
Inadequate coordination in health research takes place at many levels, and it can obviously 
involve significant costs. These costs are borne both by researchers and by the donor agencies 
which fund them: 
• For the researcher, donor fragmentation greatly increases the amount of time and effort 
that must be spent in putting together a coherent funding package of sufficient magnitude 
to permit a meaningful level of activity. This is time and effort that cannot be spent on 
research itself, thus detracting from research productivity. Upon occasion, the 
10 Iki p. xvii 
P. 29 
121993 World Development Report, p. 152. 
u Ibid., p. 169. ' ikLd.. p. 148. 
s Ibid., pp. 167-68. 
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difficulties caused by fragmentation can approach the catastrophic. For example, a 
prominent African field health research institute nearly went bankrupt while receiving 
generous project funding from multiple donors in a wide range of areas, because of 
inadequate support for the institute's core administrative functions. 
• For the donor agency, the costs are equally significant. Anything that reduces the 
efficiency of the researcher produces a comparable reduction in the efficiency of any 
support provided to his or her research. Fragmentation and lack of coordination also 
give rise to the spectre of duplication and associated waste. 
There can, of course, be too much of a good thing like coordination. A certain amount of 
diversity among donor agencies can be an important way of increasing the degree of choice that 
researchers having in choosing topics and research methods. Also, in a situation of uncertainty - - which is inherent in dealing with research -- concentration can greatly increase risk. To have 
all research funds go to support a single line of activity could be much less productive than a 
more diversified strategy should the one line selected not prove as promising as initially 
anticipated. 
To most researchers and donor representatives, however, the dangers of inadequate coordination 
probably appear much more urgent than do the dangers of over-coordination like those just 
mentioned. In fact, the need for greater coordination is probably one of the few topics related 
to support for health research about there appears to be a consensus among donors and members 
of the developing country health research community. 
II. Needs 
For the reasons indicated, there is a clear need to strengthen the contribution of health research. 
Looking more closely, it is possible to identify three particular requirements, one arising from 
each of the three issues identified in the preceding section. These requirements need to be met 
at both the national and the international levels. They are: 
A. Capacity Development 
A concern for capacity development grows out of the need to increase the quantity and quality 
of health research noted previously. Capacity development has attracted particular attention at 
the national level, especially with respect to developing countries. It is widely viewed as the 
most appropriate use of the additional resources in settings where research infrastructures require 
strengthening in order to ensure that additional funds will lead to high-quality results. The 
relevance of capacity development is by no means limited to developing countries, however. 
It is also possible to think of strengthened international capacities for research on the health 
problems of poor areas -- through, for example, the establishment of international institutes in 
developed or advanced developing countries to undertake or serve as resource bases for such 
research. 
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Capacity development has been a particular theme of the Commission, whose report argued that, 
"strengthening research capacity in developing countries is one of the most powerful, cost- 
effective, and sustainable means of advancing health and development."6 It and its successor 
institutions have actively pursued this theme, and a major strategy paper on research capacity 
strengthening is currently under development. 
B. Priority Research 
Pressing as the need for greater capacity unquestionably is, few would wish to maintain that 
capacity development is the whole story. For a great deal of capacity already exists, particularly 
at the international level and in many developed countries. As indicated earlier, this capacity 
needs to be applied more effectively to issues of importance for improving health conditions. 
There is need, in other words, for much greater relevance of the research undertaken. 
This can best be illustrated with respect to disease-specific research, in which capacities have 
been further developed than in many other areas. From the WDR emerge three broad 
considerations that can help guide research and development priorities, especially at the 
international level: first, the amount of death and disability caused by a particular disease or 
condition; second, the availability of cost-effective technologies for dealing with that condition; 
and third, the prospects for developing more cost-effective interventions. Highest priority for 
research would go to developing new approaches for dealing with diseases that cause large 
amounts of death and disability, where present methods for dealing with the disease arc 
inadequate, and where the prospects for the development of more cost effective interventions arc 
promising. Annex A provides an illustration of the research priorities that might emerge from 
the application of such an approach. 
The need for more relevant work is by no means limited to the disease-specific research, 
however. There are pressing needs in other areas, as well. For example, the WDR deals at 
considerable length with the policy issues that arise from the structural transformations from 
centrally-directed toward more market-oriented health systems in many parts of the developing 
world. Policy makers urgently want and need research from economists and social scientists to 
help them deal with the new questions raised by these transformations. They also need 
assistance from the social science research communities in dealing with the social and gender 
factors that determine inter-group differences in health status, and in understanding household- 
level behavioral considerations that play such an important role in influencing health conditions. 
C. Consultation 
The third need, flowing from the inadequacy of present coordination arrangements, is for greater 
and more effective consultation among donor representatives and those associated with research 
in developing countries. Certainly, a great deal of consultation is already occurring through 
16 Health Research, p.71. 
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frequent, if largely ad hoc, international meetings like that taking place in Ottawa; through 
WHO's Advisory Committee on Health Research; and through country-level arrangements like 
those in Zimbabwe, Bangladesh, Mozambique, and Senegal referred to in the WDR.'7 
Yet despite all this, the coordination problems noted above continue to exist. Something better 
is clearly needed. The Ottawa Conference paper on increasing and redirecting external health 
assistance deals with country-level coordination of overall resource flows. Many would argue 
that there is a need for something comparable with respect to health research, at both the country 
and the international levels. 
III. Options 
Once needs have been identified, it will be necessary to consider options for filling them and 
to determine a suitable mechanism for this purpose. Since the options most worthy of 
consideration will depend upon the nature of the needs to be filled, any detailed assessment of 
options in advance of the discussion in Ottawa concerning needs would be premature. 
It is, however, both possible and important at least to begin thinking about options. This can 
perhaps best be done through reference to a set of illustrative possibilities. What's presented 
here is a limited number of such possibilities, selected on the basis of the frequency with which 
they have arisen in recent considerations of relevance and coordination issues. 
In any possibility that might be considered, there would clearly need to be a central role for the 
international agencies that have been playing such a constructive role in international health to 
date. These would no doubt include the World Health Organization, as the lead international 
agency concerned with health research; the World Bank, as the principal multilateral financial 
supporter of health activities and the agency that has so effectively called attention to the 
pressing issues noted at the outset through its 1993 World Development Report; and the United 
Nations Development Programme, which has a distinguished history of working with both WHO 
and the Bank on inter-agency health initiatives. 
One option, certainly, would be to leave it to one or more of these agencies to deal with the 
needs that have been identified, either in the manner it best sees fit or within the framework of 
a specific mandate or charge recommended by Ottawa Conference participants. Beyond this are 
numerous possibilities based on recent experiences in health and related areas of development. 
Four such possibilities for complementing the current work of the leading international agencies 
are presented. Each deals with a possible mechanism for dealing with the issues and needs 
discussed earlier. The first two possibilities concern institutions already involved with health 
research; the other two look for inspiration to mechanisms that have worked well in other areas 
' 1993 World Development Report, p. 168 
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of development. The four possibilities are by no means mutually exclusive: it might be desirable 
for one to fill some of the needs referred to above, and another to be concerned with the other 
needs; or to turn to some alternative option incorporating be best features of each of the four. 
A. Emulating the Tropical Diseases Research (TDR) Programme and the 
Human Reproduction Programme (HRP) 
The UNDP/World Bank/WHO TDR and HR Programmes are well enough known in health 
circles not to need any further extensive introduction. As indicated in the passage from the 
WDR cited at the outset, they have produced noteworthy results. 
In the process, each has developed a reputation for dealing effectively with the three needs 
outlined in section II, as they pertain to its areas of concern. That is, each has stimulated a 
great deal of research on priority issues, has been actively engaged in capacity development, and 
has featured active inter-donor consultation in the establishment and implementation of priorities. 
One of the possibilities that could be considered is the establishment of programs like TDR and 
HRP in other areas of health research. For example, one might imagine a TDRIHRP-like 
program dealing with one or more of the important disease priorities appearing in annex A, or 
focusing on issues associated with health sector reform. 
B. Linking with the Council on Health Research for Development (COHRED) 
COITRED is a recently-established successor to the Commission on Health Research for 
Development, whose 1990 report has figured prominently in this paper. It is governed by a 
group of leading developing country health research policy-makers and donor representatives. 
COHRED's principal activity at present is to coordinate the preparation of locally-developed 
priorities for Essential National Health Research in some 15-20 countries of Africa, Asia, and 
Latin America. It is supported by a consortium of donors led by IDRC of Canada and SAREC 
of Sweden. Its small secretariat is located in Geneya. 
Thus far, COHRED has been more active in dealing with some of the three needs listed in the 
preceding section than with others. Its focus has been on stimulating priority research at the 
national level; it has been less concerned with research at the international level. It has done 
little to date with respect to capacity building but has begun to turn its attention to this issue 
through preparation of the strategy paper referred to earlier. As a multi-donor initiative, it has 
proven quite effective in drawing together both donor and developing country representatives to 
deal with the issues of mutual concern. 
As COHRED's leaders are among the first to point out, COHRED is just now beginning to find 
its way. This raises the question of how many different responsibilities it should try to take on 
how soon. But there is general agreement that COHRED deserves to be strengthened; and 
encouraging it to undertake additional functions as soon as feasible remains an important option. 
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C. Looking to the Consultative Group on InternationalAgricultural Research 
(CGIAR) 
The CGIAR is a consortium of donors providing some $260 million of support annually to 
nearly 20 international agricultural research centres, primarily in the developing world. The 
CGIAR and its centres have made widely-recognized contributions to agricultural research, 
notably through the development of high-yielding wheat varieties at the Mexico centre and 
highly-productive rice strains in the Philippines. 
With respect to the three needs laid out in the preceding section, the CGIAR has been most 
obviously successful in dealing with two. The first has been in stimulating high-priority research 
with respect to individual crops at the CGIAR-assisted international centres. The second has 
been in facilitating coordination among a large number of donors in mobilizing financial 
resources to support this research. It has been less well known for developing research 
capacities or for assisting research at the national level. 
The possibility of establishing a CGIAR-like mechanism in health has attracted widespread 
attention. It is mentioned in the WDR'8 and discussed in accounts of the Report's contents.19 
It is also covered at some length in the Commission's report. The Commission found the 
CGIAR experience highly relevant for health. In general, it favoured using it as a means of 
strengthening national institutions, with international centres like those supported by CGIAR 
being reserved for special cases.2° 
This suggests the possible desirability of a CGIAR-like institution to coordinate and raise funds 
for a diverse set of health research organizations. These might perhaps include leading national 
health research programs, some international networks dedicated to the strengthening of national 
research institutions (such as TDR, HRP, and networks belonging to the Puebla Group), and a 
few international institutes (such as the ICDDR,B). 
D. Learning from the Donors to African Education (DAE) 
DAE is a consortium of some forty international, national and private donor agencies formed 
in 1988 as an outgrowth of a World Bank report on education in Africa. Its objective is to 
provide a forum for policy dialogue, consultation, and joint planning between African 
governments and donors, and among the donors. DAE activities are directed by an executive 
committee of African education officials and donor representatives. The activities are of three 
types: continuing dialogue on policy options through regular meetings of DAE members; support 
18 Ibid., p. 169 ' 
As, for example, in the Science magazine account of the World Development Report's release. ("World Bank 
Report Calls for Network to Bolster Research, Science , vol. 261, no. 5118 (9 July 1993), p. 155.) 
Health Research, pp. 58-60. 
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for discussion and research through working groups dealing with particular topics (such as 
textbooks, higher education, capacity-building for research) and organized by different 
participating donors; and dissemination of the results produced by the working groups and the 
debates on policy options. The DAE secretariat, originally housed at the World Bank, is 
currently located in the International Institute for Educational Planning in Paris. 
Thus far, the DAE has paid greater attention to consultation and coordination than to the other 
two needs for health research listed in section II. The other two -- capacity development and 
priority research -- have not been ignored, however. As noted, there is a DAE working group 
concerned specifically with capacity development for educational research; and some of the DAE 
working groups have been providing research support. 
An unusually widespread consensus about DAE's value exists in the African education 
community, and this provides a basis for considering something similar in health as an option. 
If desired, any comparable health entity could build on DAE's strengths in the consultation area 
with more active capacity building and research support components. 
IV. Questions 
The basic question before the Ottawa Conference is which action option is best suited to the 
needs and issues that have been identified. This question can perhaps most appropriately be 
addressed in two steps. The first is to review the issues, needs, and options suggested in the 
preceding sections to ensure that they are the most important ones, and to modify them as 
appropriate. The second is to identify the particular option, from among those under 
consideration, that can best fill the most important needs. 
A. First Step 
In the first step, questions to be addressed might include: 
1. Issues. The presentation in section I featured three issues often appearing in discussions of 
health research: quantity and quality, relevance, and coordination. 
• Are these the most important issues, or are there others that should be given higher 
priority? 
• Are some of the three issues noted significantly more important than others? For 
example, would anyone wish to argue that, contrary to the position presented in section 
I, most of the health research currently being undertaken is highly relevant to developing 
country health concerns; and that relevance is thus not a major issue? 
2. Needs. Section II deals with three needs, derived from the three issues referred to in section 
I. These needs are: capacity development, priority research, and more effective consultation. 
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• Are these the needs that follow most logically from the issues raised? 
• How important is each need relative to the others? For instance, should more importance 
be attached to strengthening research capacities, especially in the developing countries, 
or to applying the capacities that now exist to undertake priority research? 
• Has each need been correctly outlined? Speaking of priority research, for example, can 
the most important issues best be identified through an epidemiological approach like that 
suggested in section II; or should primary reliance be placed on some other method, such 
as guidance by the views of the population served or of policy makers about issues of 
greatest concern to them? 
3. Options. Section III notes the importance of the World Health Organization, the World 
Bank, and the UNDP in any instrumentality that might reasonably be considered. The text then 
goes on to suggest four possibilities, one each based on models that have worked well or appear 
promising in other areas of health and development: TDRIHRP, COHRED, CGIAR, and DAE. 
• These are obviously but four of many possibilities that could have been put forward.2' 
Are there others which are perhaps even more promising, or which contain features 
worthy of note? 
B. Second Step 
Once the range of important issues, pressing needs, and promising options has been clearly 
identified, it will be necessary to choose. That is, further progress will require selecting from 
among the available options on the basis of their suitability for the needs at hand. 
The choice will no doubt be difficult and will involve answering many questions. Among them 
are: 
• Are existing institutions and programs sufficient to increase the quantity, quality, and 
relevance of health research to the extent desirable; and/or to fill any other needs 
identified by Conference participants? Or is there a case for a special initiative? 
• What should be the principal emphasis of any special initiative? For example, should it 
focus on essential research at the national level, or at international research on global 
issues? Should it give highest priority to strengthening capacities; to promoting research 
on high-priority issues using existing capacities; or to ensuring more effective 
consultation among donors, policy makers, and/or researchers? 
21 For example, the COHRED report on research capacity strengthening referred to earlier includes a discussion 
of lessons to be learned from the International Network for the Improvement of Lathyrus Sativus and the Eradication 
of Lathyrism (INISEL). 
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• How should any such initiative be organized and administered? Should it be given over 
to one or more of the leading international organizations, or would some supplementary 
mechanism be more appropriate? If a supplementary mechanism, what should be its 
principal features? 
• Who would pay? How much would the donor agencies participating in the Ottawa 
Conference be prepared to contribute to any attractive proposals emerging from the 
Conference? 
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Annex A 
Illustrative priorities for research and product development funding established by examining the burden of 
particular conditions, the cost-effectiveness of present interventions, and prospects for innovation. 
Morbidity and 
premature mortality Illustrative research priorities for 
burden in developing Cost-effectiveness of prevention, treatment, and case 




125 Cost-effective interventions 
exist for most of this 
burden, 
Operations research to lower 
intervention costs and to improve 
ease of delivery in rural areas. 
Respiratory 
infections 
119 Cost-effective treatment 
exists to deal with about 
40% of acute respiratory 
infections (those that 
respond to antibiotics). 
Patient compliance with 
drug treatment is a 
problem. 
Operations research directed at 
cost-effective ways to reduce 
indoor air pollution. Inexpensive 
or simplified antibiotic regimens. 





99 Oral rehydration therapy is 
cost-effective but only 
suitable for treatment of 
about 40% of the disease 
burden, 
Rotavirus, enterotoxigenic e.coli 
vaccines. Improved cholera 
vaccine. Ways of improving 
hygiene. Better case management 
of persistent diarrhea. Prevention 
of diarrhea by the promotion of 










immunizations exist, but 
coverage needs to increase, 
New and improved vaccines to 
reduce number of patient 
contacts, delivery of vaccines 
earlier in life, and improve heat 
stability in some cases. 
Tuberculosis 46 Cost-effective interventions 
exist. Drug resistance and 
compliance are problems. 
Operations research on more 
effective compliance. Monitoring 
tools for drug resistance. 
Simpler diagnostics for use in 
health centres. New and cheaper 
drug treatment protocols. 
*Millions of disability-adjusted life years 
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Illustrative priorities for research and produ 
particular conditions, the cost-effectiveness 
Ct development funding established by examining the burden of 
of present interventions, and prospects for innovation. 
Morbidity and 
premature mortality Illustrative research priorities 
burden in developing Cost-effectiveness of present for prevention, treatment, 
Condition countries* interventions and case management 
Ischemic heart and 42 Some tobacco control Research on low-cost 
cerebrovascular measures are highly cost- management of condition. 
disease effective. Cost-effective 
post-stroke or post- 
myocardial infarction 
management is possible 
through behaviour 
modification and appropriate 
medication. 
Sexually 41 Cost-effective treatment Low cost diagnostic tests for 
transmitted exists for symptomatic gonorrhea, chlamydia, 
diseases (excluding individuals. There are chancroid, trichomoniasis 
HIV) problems from asymptomatic and syphilis suitable for use 
infection, high-cost in health centres. Female- 
diagnostics that cannot be controlled, nonintrusive 
carried out in a health centre, method of prevention (e.g. 
and lack of a female- vaginal virucide). Treatment 
controlled method of algorithms for reaching 
prevention. asymptomatic women. 
HIV 28 Some cost-effective Female-controlled prevention 
approaches to prevention methods, such as vaginal 
have been identified. No virucides. AIDS vaccine for 
effective cure exists. Drugs prevention, therapy, and/or 
prolonging life are very prevention of transmission 
expensive, from mother to fetus or 
infant. Simplified HIV 
diagnostic tests with lower 
costs. 
Motor vehicle 26 Taxes on alcohol represent a Operations research to 
collisions cost-effective approach. identify and test additional 
cost-effective interventions 
such as driver education 
campaigns and improving 
highway "danger spots." 
Helminths 18 Cost-effective drug Operations research directed 
treatments exist for many at expanding coverage. 
helminths but exclude Verification of drug safety 
potentially pregnant and during pregnancy to expand 
lactating women, coverage. Multi-disease 
chemotherapy. Recombinant 
vaccines for schistosoiniasis. 
Source: Background material for the 1993 World Development Report 
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In creasing_and_Redirecting External Assistance for Health 
External assistance for health, estimated at US$4.8 billion in 1990, amounts to a less than 3 
percent of health expenditures in developing countries. But it can constitute a significant portion 
of the investment budget (and, in some countries, a large portion of the total health budget), and 
it can play an important catalytic role in health policy reform. One objective of the Ottawa 
Conference is to discuss and agree to actions to increase the level and improve the effectiveness 
of external assistance through strengthened partnerships among the international community and 
governments. 
Currently, there is a mismatch between key international policy statements on health and trends 
in ODA. A strong consensus emerged in the 1980s on many fronts that investments in human 
development are central to economic and social development, and merit high priority for 
governments and donors alike. Yet official development assistance (ODA) for health as a share 
of total aid declined over the 1980s: health's share of ODA fell from eight percent for the period 
1981-85 to 6.5 percent for the period 1986-90 after increasing steadily over the 1970s.1 Many 
low income countries, particularly in Sub-Saharan Africa, will need more assistance just to reach 
a very minimum level of health care. 
Equally important, the effectiveness of external assistance and domestic resources offers much 
room for improvement. There continues to be substantial donor spending on sophisticated 
hospitals and equipment that provide services of low cost-effectiveness, primarily to the 
better-off in developing countries. The efficiency of donor support is also weakened by the 
existing fragmentation of external assistance to many countries. This efficiency is also 
constrained by important gaps in donor interest and expertise, particularly in the areas of health 
policy reform. This paper analyzes the role of donors in helping to reshape health policies and 
in improving domestic resource mobilization for health in developing countries. The paper 
focuses on five key questions2 that are explored in more detail in the sections that follow: 
• How can donors improve the allocation of aid? 
• How can they reduce the resource gap in the poorest countries that prevents them from 
providing a minimum package of services to the poor? 
• How can they address weaknesses in donor expertise? 
'ODA is defined as resources administered with the promotion of economic development as their main objective, 
that contain a grant element of at least 25%. Total external assistance is a broader concept. It is made up of ODA, 
multilateral loans, and NGO flows. See Michaud and Murray 1993. 
2These areas are intended to provide the basis for a much expanded discussion on aid effectiveness, not 
necessarily limited to the issues and options presented here, at the Ottawa conference. 
• How can they address weaknesses in donor expertise? 
• How can donors enhance country-level coordination of donor involvement in health 
policy dialogue and financial aid for health? 
• How can they address the stagnation of overall flows for health as a share of ODA? 
Issue 1: Aid is misaiocated 
Investments and technical cooperation are often made with insufficient attention to the cost-- 
effectiveness and equity implications of such investments. There continues to be support for 
investments in new tertiary hospitals in low-income countries while the most cost-effective health 
interventions, delivered at lower levels of the health pyramid (communities, health centres, and 
district hospitals), remain underfunded. At the same time, soft investments to improve the 
management and efficiency of existing hospitals are badly needed. 
To improve the allocation of aid, external assistance needs to be delivered within the framework 
of a country-level strategic health plan. This health plan could define the package of public 
health interventions and essential clinical services that the government will strive to finance, for 
at least a portion of the population, and specify the policies, training and physical investments 
needed to deliver that national package. External assistance coupled with shifts in domestic 
spending could then be directed to those needs. 
This national package should not be defined internationally and uniformly applied to all 
developing countries. Countries need to take the lead in defining their own packages and the way 
they will be delivered locally. The World Development Report 1993 presented an illustrative 
"minimum package" of public health interventions and essential clinical services worthy of 
consideration in most developing countries, because of the magnitude of the burden of disease 
that they address and their high cost-effectiveness. Some of these interventions (e.g. TB 
treatment and STD prevention and treatment) are still badly neglected. In the case of AIDS, the 
World Development Report 1993 called for an additional US$ 500 million a year in external 
assistance to meet one-quarter of the estimated costs of stabilizing the AIDS epidemic. 
Comprehensive and coherent country-level strategic health plans could be prepared by drawing 
on the country's best public health specialists and political strategists, with donor assistance as 
necessary. A national consensus for the strategic plan could be sought through the process of 
public debate of the findings and recommendations. These plans would offer many benefits. 
They would increase in-country ownership of the ideas and proposals and help governments take 
more control of domestic and external assistance priority setting. If the strategic plans were 
convincing in their priorities, and assured the sustainability of investments, they would provide 
a strong basis for donors to argue successfully for incremental resources for that country. 
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Within any sort of strategic plan, external assistance will need to support long-term capacity 
building, especially in health information, policy analysis and management, and training in 
public health and primary care. More external assistance needs to be directed at biomedical 
research to expand the range of cost-effective treatments and at operational research to 
determine how to best deliver those interventions efficiently. Both capacity building and health 
research will be discussed in separate working groups at the Ottawa Conference. 
Identifying the right priorities is an essential first step. Another crucial step in increasing the 
impact of external assistance is to improve the quality of project or technical assistance design 
and implementation, with special attention to project sustainability. Project sustainability can 
be increased if there is a sound policy environment and adequate maintenance and support 
systems. Currently, however, donors' instruments for technical assistance and investments are 
often inflexible and thus reduce efficiency and sustainability. Tied procurement can result in 
inefficient purchases. 
Restrictions on financing local costs bias projects towards capital and import-intensive goods and 
services that cannot be sustained once donor funding ceases. 
Options for Ottawa. The donor community can do much more to improve the allocation of 
current levels of aid for the health sector. The Ottawa Conference could, for example: 
• discuss how to encourage the preparation of country-level strategic health plans by 
governments over the short to medium term, and consider a choice of mechanisms to 
assist in the process. A global funding mechanism could be established, for example, to 
provide grant funding for this purpose. 
• seek consensus that increased external assistance should be directed for nationally-defined 
packages of clinical services and public health interventions, and call for a specific target 
for external assistance for these packages. 
• seek consensus for the need for and identify specific external assistance targets for 
capacity-building. 
• identify measures to encourage more recurrent cost financing in the poorest countries, 
and to untie aid. 
• agree on the need to improve monitoring of the use of external resources and establish 
the next steps to do so. 
• reach a consensus for a moratorium on donor support for new tertiary hospitals and 
sophisticated medical equipment in countries where the national package is not 
universally available. 
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Issue 2: The poorest countries need even greater assistance if a minimum 
package is to be provided to their populations 
In many low-income countries there is a significant resource gap between health care spending 
and the costs of the minimum package presented in the World Development Report 1993. The 
Report estimated that it would cost an additional US$10 billion to deliver the package in 
low-income countries. How far this gap can be filled by reallocation of public spending, 
increased targeting of the national package to the poor, and greater domestic resource 
mobilization for health can only be decided on a country-by-country basis. In policy discussions 
with the Ministries of Finance, Planning and Health, donors can try to facilitate these changes. 
Yet in many low-income countries greater external assistance will clearly be needed to help close 
this resource gap. The minimum package was estimated to cost about US$12 per capita in 1990 
dollars, but at present public spending is below US$5 per capita in at least 11 African countries 
containing almost 60 percent of the region's population. Similarly, in Asia the public sector 
spends less than US$5 per capita in Bangladesh, India, Lao PDR, Nepal, and Vietnam, with a 
combined population of over one billion. 
To help close these resource gaps, donors can increase aid flows, linking aid to shifts in 
domestic expenditure, and can target existing levels of assistance to poorer countries and, within 
countries, to poorer populations. It is well known that geopolitical and commercial 
considerations play a strong role in aid allocation; analyses of the relationship between ODA and 
per capita income find very little relationship between these two factors. Just as countries spend 
their resources inequitably, so do donors. Even within countries, richer regions often absorb a 
higher per capita share of assistance. 
Table 1. Per Capita External Assistance by Region, 1990 
Per Capita Aid 
Region (US$) 
Sub-Saharan Africa $2.45 
Latin America and the Caribbean $1.33 
Middle Eastern Crescent $1.31 
Other Asia and Islands $0.87 
India $0.34 
China $0.07 
Note: For an explanation of regions, see World Development Report 1993. 
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On a regional basis, external assistance has been heavily focused on Sub-Saharan Africa, making 
up almost 15 percent of total health expenditures in that region in 1990. On a per capita basis, 
as well, Sub-Saharan Africa is the largest recipient of health aid flows (Table 1). Some 
countries are heavily aid-dependent: in Mozambique, for example, aid accounted for more than 
half of recurrent spending and for 90 percent of capital expenditures for health in 1991. 
Consultative group meetings can be used as a mechanism to obtain sector-wide pledging of 
assistance. This has been used successfully in Tanzania and Zambia. If the country's absorptive 
capacity for more external assistance is a constraint, consultative group meetings can also be 
used as a mechanism to explore how best to address this problem. Local NGOs might be able 
to deliver more services in cases where government absorptive capacity is constrained. 
Options for Ottawa. The Ottawa Conference could discuss how external resources could be 
better targeted to poor countries in order to help pay for a minimum package in those countries, 
and how policy dialogue could encourage greater domestic resource mobilization and reallocation 
for health. The Conference could: 
• agree to a target threshold level of services (such as those presented in the "minimum 
package" in the World Development Report 1993) for the poor in all countries. 
• set a target of external assistance for this in the poorest countries, and identify practical 
steps in this direction. For example, the Conference could take steps to support the 
World Development Report 1993's call for an additional US$1.5 billion in external 
assistance for the poorest countries for the package. 
• call for greater donor support of recurrent costs in the poorest countries. 
• sponsor a selective evaluation of those low-income countries that have received relatively 
large amounts of external assistance for health but show poor results, in order to draw 
lessons for governments and the international community. 
Issue 3: Gaps in donor expertise constrain the effectiveness of aid for 
health 
Just as capacity building is critical in developing countries3, donors need to build up a greater 
reservoir of skills and expertise to assist developing countries in many key problems facing 
countries today. Some of these problems have emerged from changes in the burden of disease 
or changes in interventions required to address diseases, such as the challenges posed by the 
3This topic is examined in more depth in the issues paper on "Capacity-Building for Health Policy and Health 
Systems Reform". 
Conference Discussion Paper B.3 - v - 
spread of AIDS, the health needs of aging populations, and the steady evolution of drug resistant 
microbes. Other problems relate to health finance and delivery policies, and here industrialized 
countries are searching for answers, too. In health policy reform, donors need to avoid the 
temptation to promote one model, but instead encourage a diversity of approaches, drawing on 
the lessons learned from many countries. There is also heightened awareness of the need to 
address long-standing problems, such as violence against women, but tools to do so are poorly 
developed. And even in areas where donors have worked for some time, such as in investments 
in equipment and facilities, success to date in establishing sustainable maintenance systems is 
limited. Examples of gaps in donor expertise are presented in Table 2, and include such areas 
as the use of cost-effectiveness and national burden of disease methodologies for priority-setting, 
civil service reform, and health services decentralization. 
Table 2. Examples of gaps in donor experience and expertise 
Broad Areas Gaps in experience and expertise 
Health systems Essential equipment lists, equipment maintenance, referral systems, quality 
assurance systems 
Health policy Civil service reform, systems to link facility budgets better to 
performance, cost accounting and autonomy, health services 
decentralization 
Health research Neuropsychiatric problems. Research priorities could be established, in 
part, by examining the global burden of disease and the cost-effectiveness 
of existing interventions to address those conditions in order to identify 
conditions where cost-effective interventions need to be developed. 
Health information National burden of disease. Cost accounting and management information 
and analysis systems. Cost-effectiveness analysis. 
Gaps in donor expertise could be identified so that different donors, or groups of donors, could 
take the lead in building up their skills and technical assistance/investment in different areas. 
This would require a frank and informed discussion to explicitly identify which agency or NGO 
might have comparative advantage in a certain area. Comparative advantage is based, in part, 
on the type of instruments different agencies have at their disposal for external assistance. The 
UN agencies focus on technical assistance. Multilateral banks, the EC, and OPEC provide grants 
and loans to the health sector. NGOs have their own distinct advantages: they usually have a 
high proportion of field staff and are grass-roots oriented, they tend to have low operating costs, 
and are often independent of government politics. Comparative advantage will also depend on 
the experience different donors have gained to date, the skills mix of their staff (or access to 
contracted out expertise), how closely they work with NGOs, how many field staff they have, 
among other factors. The identification of comparative advantage is a process that could begin 
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at the Ottawa meeting and continue in the form a follow up working group. It may be desirable 
for several donors to work together on certain key areas. In some cases, donors have already 
assumed leadership in certain areas. This could be made more explicit and methods of 
collaboration could be identified to build on that expertise. Illustrative examples of current 
expertise include: 
• Belgium and Switzerland: district health systems management. 
• Denmark and Norway: water and sanitation. 
• Germany: maintenance of medical equipment. 
• Rockefeller Foundation: public health training programs. 
• UNICEF: micronutrient deficiencies, immunization programs. 
• WHO: essential drugs, tropical disease research, AIDS prevention. 
Greater south-south collaboration also merits support in these emerging areas. Chile, for 
example, is implementing far-reaching health policy reforms. It has supported health services 
decentralization and the encouragement of privately owned and operated health insurance funds. 
In the process it has had to face many problems and adjust its strategy. Chile could provide 
guidance to other countries considering similar reforms. The Tunisian government is 
implementing a public hospital reform program, granting public hospitals more budgetary and 
administrative autonomy. It may have much to offer in assisting other countries with similar 
reforms. 
Options for Ottawa. The Ottawa Conference could: 
• systematically tabulate gaps in donor capacity at the Conference and identify what donors 
might take the lead in building up their skills and technical assistance/investment in 
different areas. 
• identify a mechanism to systematically share information about expertise across donors 
and expertise available in the private sector. 
• look to the future to assess upcoming challenges in the health sector and how to prepare 
for them. 
Issue 4: Country-level coordination is inadequate 
Poor country-level coordination of external assistance can result in heavy burdens on country 
governments, wasted resources, and excessive transaction costs for both governments and 
donors. Donor agencies often have different budgetary, procurement and accounting 
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requirements for investment projects and technical assistance. This can be a management 
nightmare for countries working with several donors. Donor demands on government officials' 
time can be staggering: WHO calculated that the project director of a health project in West 
Africa was out of post for 120 days in a year when all the donor-sponsored events were added 
together. Donors can also work at cross purposes to each other. The World Development Report 
1993 noted that recently in one West African country three different cost recovery policies, 
supported by three different donor agencies, were in place in different regions of the countries. 
In some countries where donors each work in a different province, this can undermine the 
formulation of coherent national health policies. Some policy differences among donors are 
inevitable--donors can agree to disagree. But in other cases policy advice differs at the 
country-level because donors have not taken the time to work out their differences. 
Recipient governments have the main responsibility for aid coordination. Donor agencies can 
facilitate such coordination by strengthening governments' ability to lead, supporting consultative 
group meetings or round tables, and cofinancing projects. They can also seek opportunities for 
joint policy work. 
Health needs to be on the agenda of consultative groups, donor round tables, and other major 
fora where development assistance is discussed on a country-by-country basis. Even more 
important are informal country-level meetings and information sharing. Donors could help 
create informal local groups to meet periodically with the government to review progress and 
problems in the health sector, as is done in Mozambique and Senegal. Such aid coordination 
is facilitated by the presence of policy-oriented staff stationed in the recipient country. 
Donor cofinancing of important health projects and programs can reduce administrative burdens. 
both to government and to donors, by unifying procedures and simplifying the dialogue between 
the government and international community. Co-financing has the potential to improve project 
quality by building on different donors' skills and expertise. Multi-donor financed health and 
population projects in Bangladesh and Zimbabwe attest to the strengths of on-the-ground donor 
coordination. Broad inter-agency agreements to co-finance can also help at country level; 
UNiCEF's recent invitation to the World Bank to combine forces to address the problem of 
iodine-deficiency in several regions is one such example. 
A consensus among donors on policy advice is also important; conflicting advice can often be 
counterproductive. Joint sector assessments and policy studies involving several donors can help 
to build this consensus. Health policy discussions with governments also need to take place in 
the context of broader debate on inter-sectoral priorities and macroeconomic policies related to 
domestic resource mobilization and the allocation of public spending. 
Options for Ottawa. The Ottawa Conference could: 
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• call for the systematic exchange of planned and ongoing policy work4, completed policy 
papers and strategy documents. 
• identify specific mechanisms to facilitate better information exchanges among donors and 
to promote joint policy work, cofinancing and consultative groups, and to encourage field 
offices to work more closely together. 
• consider the establishment of electronic mail networks to connect governments and 
donors (globally and in-country) for a more continuous exchange of information. 
Issue 5: Overall flows for health, as a share of ODA, are stagnant or falling 
The UNDP has argued for more donor spending on health in its annual Human Developmenl 
Report and the World Bank has made similar recommendations in its recent World Development 
Reports. These and other policy documents have made compelling cases for increasing aid for 
health. Despite this, health assistance as a share of total ODA fell in the late 1980s, from eight 
percent for the period 1981-85 to 6.5 percent for the period 1986-90 after increasing from an 
average of three percent in 1973-76 to seven percent in l985. Bilateral health aid flows 
declined from about seven percent of ODA during 1980-85 to five percent from 1986-90, while 
multilateral health aid flows increased substantially. On current trends, the share of multilateral 
agencies, including nonconcessional loans, is likely to continue to grow and to account for 
roughly half of health ODA by the mid 1990s. 
The health community might look to models in the environmental area for attracting more 
resources to the sector. Examples include the Montreal Protocol, where countries pledged 
monies for a trust fund to support projects designed to reduce the discharge of ozone depleting 
substances into the atmosphere. Similarly, the Global Environment Facility, or GEF, is another 
example of a trust fund to support studies and investments for environmental projects. 
Better monitoring mechanisms are desirable so that both the volume and uses of aid can be 
monitored in a more timely fashion.6 But more importantly, thought needs to be given to how 
to reinstate, or even increase, health's share of ODA. This share increase would come at a 
difficult time, given stagnant, or even declining aid budgets in many countries. But for the 
4Reporting work in progress, with the name of the person responsible, would facilitate informal contacts. 
5For a detailed discussion of these trends, see Michaud and Murray 1993. 
6The Development Assistance Committee (DAC) of OECD produces an annual report of ODA, but only direct 
bilateral assistance is broken down by sector. Multilateral assistance is not monitored by sector. Studies of health 
sector external assistance broken down by country or activity depend on the Creditor Reporting System (CRS). The 
CRS has very poor coverage: it was estimated to be only 63% complete for health. Coverage fluctuates by donor 
and year. See Michaud and Murray 1993, for a full discussion. 
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multilateral banks and certain bilaterals the total resource envelope is still growing, and 
increasing flows for health should be supported. The World Development Report 1993 called 
for an additional US$2 billion from donors annually to meet about one-quarter (or US$.5 billion) 
of the costs of stabilizing the AIDS epidemic, and one-sixth (or US$1.5 billion) of the extra 
resources needed to deliver the "minimum package" presented in the report in low-income 
countries. 
At the same time, donors must recognize the importance of intersectoral actions for health - the 
need to improve the "enabling" environment for health. This includes supporting economic 
growth policies that will benefit the poor, expanding investments in schooling, particularly for 
girls, and promoting the rights and status of women. 
Options for Ottawa. The Ottawa Conference could: 
• consider whether it would be feasible to pursue a target of US$2 billion, or a higher one, 
in pledges of greater assistance to health, and within that, for certain problems and 
countries. 
• consider the pros and cons of a new global funding mechanism — some sort of trust fund, 
and, if there is support, initiate further work to explore the feasibility of such a 
mechanism. 
• discuss whether better external assistance monitoring mechanisms should be developed 
and, if so, identify the next steps. 
Follow up to Ottawa Conference 
If concrete action is to emerge out of our discussions at Ottawa on these five issues and on 
others, it will be important to prioritize where there is consensus that specific actions are needed 
to improve quality and to increase overall levels of external assistance in health. We will need 
to initiate small working groups, or a similar mechanism, to carry on with specific tasks 
following the Ottawa Conference. And it will be essential to establish a reporting mechanism for 
those working groups and identify how the donors, as a larger group, will meet on a regular 
basis. 
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